Evidence map›Paper›PMID 28863132›Full record

ArticlePloS one2017

A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells.

Stefanie Homann, Christian Hofmann, Aleksandr M Gorin, Huy Cong Xuan Nguyen, Diana Huynh, Phillip Hamid, Neil Maithel, Vahe Yacoubian, Wenli Mu, Athanasios Kossyvakis and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. An Overview of Methods and Tools for Transfection of Eukaryotic CellsFrontiers in bioengineering and biotechnology · 2021
    Review
  7. Article
  8. STAR protocols · 2020
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Stefanie HomannDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Christian HofmannDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Aleksandr M GorinDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Huy Cong Xuan NguyenDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Diana HuynhDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Phillip HamidDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Neil MaithelDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Vahe YacoubianDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Wenli MuDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Athanasios KossyvakisDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Shubhendu Sen RoyDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Otto Orlean YangDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.
Theodoros KelesidisDavid Geffen School of Medicine at University of California Los Angeles, Los Angeles, United States of America.ORCID http://orcid.org/0000-0002-8463-3811
University of California, Los Angeles · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JAMIESON-KARAVODIN, BETH DEIRDRE · 1991 to 2018
$39.9M
UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Oxidized HDL in the intersection of HIV, immune activation and atherosclerosisK08AI108272 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KELESIDIS, THEODOROS · 2013 to 2017
$915k
NCATS NIH HHS UL1 TR000124NIAID NIH HHS K08 AI108272NIAID NIH HHS P30 AI028697
6 · The paper itself

Abstract

Transfection is one of the most frequently used techniques in molecular biology that is also applicable for gene therapy studies in humans. One of the biggest challenges to investigate the protein function and interaction in gene therapy studies is to have reliable monospecific detection reagents, particularly antibodies, for all human gene products. Thus, a reliable method that can optimize transfection efficiency based on not only expression of the target protein of interest but also the uptake of the nucleic acid plasmid, can be an important tool in molecular biology. Here, we present a simple, rapid and robust flow cytometric method that can be used as a tool to optimize transfection efficiency at the single cell level while overcoming limitations of prior established methods that quantify transfection efficiency. By using optimized ratios of transfection reagent and a nucleic acid (DNA or RNA) vector directly labeled with a fluorochrome, this method can be used as a tool to simultaneously quantify cellular toxicity of different transfection reagents, the amount of nucleic acid plasmid that cells have taken up during transfection as well as the amount of the encoded expressed protein. Finally, we demonstrate that this method is reproducible, can be standardized and can reliably and rapidly quantify transfection efficiency, reducing assay costs and increasing throughput while increasing data robustness.

Indexed as

CRISPR-Cas SystemsDNAElectroporationFlow CytometryGenetic TherapyGreen Fluorescent ProteinsHEK293 CellsHumansJurkat CellsPlasmidsReproducibility of ResultsRNATransfectionDNAGreen Fluorescent ProteinsRNA

Identifiers

PMID28863132
PMCPMC5580984
OpenAlexW2751544109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.